(0.67%) 5 080.25 points
(0.39%) 38 216 points
(0.94%) 17 603 points
(0.78%) $79.62
(2.28%) $1.976
(-0.19%) $2 306.60
(-1.15%) $26.44
(0.40%) $958.70
(0.18%) $0.935
(0.56%) $11.09
(0.11%) $0.799
(-1.55%) $91.82
Live Chart Being Loaded With Signals
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States...
Stats | |
---|---|
Šios dienos apimtis | 188 724 |
Vidutinė apimtis | 626 109 |
Rinkos kapitalizacija | 41.47M |
EPS | $0 ( 2024-03-04 ) |
Kita pelno data | ( $-0.380 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.350 |
ATR14 | $0.00400 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Goncalves Joana | Sell | 2 753 | Common Stock |
2024-04-05 | Terrillion Scott | Sell | 2 753 | Common Stock |
2024-02-29 | Terrillion Scott | Sell | 3 293 | Common Stock |
2024-02-29 | Posner Christopher | Sell | 5 834 | Common Stock |
2024-02-29 | Goncalves Joana | Sell | 3 293 | Common Stock |
INSIDER POWER |
---|
72.39 |
Last 96 transactions |
Buy: 1 992 546 | Sell: 375 720 |
Tūris Koreliacija
Cara Therapeutics Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
AHCO | 0.982 |
MDRX | 0.978 |
TTEC | 0.974 |
TUEM | 0.973 |
UPLD | 0.972 |
APTX | 0.97 |
SSP | 0.969 |
OLPX | 0.964 |
MICS | 0.963 |
VERU | 0.961 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
CPTA | -0.959 |
XLRN | -0.958 |
FLMN | -0.955 |
ZGNX | -0.953 |
TIG | -0.952 |
ITI | -0.948 |
PPYAU | -0.948 |
RAM | -0.946 |
GPACU | -0.942 |
KTCC | -0.941 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cara Therapeutics Inc Koreliacija - Valiuta/Žaliavos
Cara Therapeutics Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $20.97M |
Bruto pelnas: | $14.54M (69.32 %) |
EPS: | $-2.19 |
FY | 2023 |
Pajamos: | $20.97M |
Bruto pelnas: | $14.54M (69.32 %) |
EPS: | $-2.19 |
FY | 2022 |
Pajamos: | $41.87M |
Bruto pelnas: | $34.60M (82.65 %) |
EPS: | $-1.550 |
FY | 2021 |
Pajamos: | $23.03M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-1.740 |
Financial Reports:
No articles found.
Cara Therapeutics Inc
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.